AU2001254563A1 - Internal de novo initiation sites of the hcv ns5b polymerase and use thereof - Google Patents

Internal de novo initiation sites of the hcv ns5b polymerase and use thereof

Info

Publication number
AU2001254563A1
AU2001254563A1 AU2001254563A AU5456301A AU2001254563A1 AU 2001254563 A1 AU2001254563 A1 AU 2001254563A1 AU 2001254563 A AU2001254563 A AU 2001254563A AU 5456301 A AU5456301 A AU 5456301A AU 2001254563 A1 AU2001254563 A1 AU 2001254563A1
Authority
AU
Australia
Prior art keywords
internal
hcv ns5b
ns5b polymerase
initiation sites
novo initiation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001254563A
Inventor
George Kukolj
Charles Pellerin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boehringer Ingelheim Canada Ltd
Original Assignee
Boehringer Ingelheim Canada Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Canada Ltd filed Critical Boehringer Ingelheim Canada Ltd
Publication of AU2001254563A1 publication Critical patent/AU2001254563A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C12N9/1241—Nucleotidyltransferases (2.7.7)
    • C12N9/127—RNA-directed RNA polymerase (2.7.7.48), i.e. RNA replicase
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24211—Hepacivirus, e.g. hepatitis C virus, hepatitis G virus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24211—Hepacivirus, e.g. hepatitis C virus, hepatitis G virus
    • C12N2770/24222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
AU2001254563A 2000-04-21 2001-04-20 Internal de novo initiation sites of the hcv ns5b polymerase and use thereof Abandoned AU2001254563A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US19879300P 2000-04-21 2000-04-21
US60/198,793 2000-04-21
PCT/CA2001/000580 WO2001083736A2 (en) 2000-04-21 2001-04-20 Internal de novo initiation sites of the hcv ns5b polymerase and use thereof

Publications (1)

Publication Number Publication Date
AU2001254563A1 true AU2001254563A1 (en) 2001-11-12

Family

ID=22734870

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001254563A Abandoned AU2001254563A1 (en) 2000-04-21 2001-04-20 Internal de novo initiation sites of the hcv ns5b polymerase and use thereof

Country Status (4)

Country Link
US (1) US20010055756A1 (en)
EP (1) EP1278837A2 (en)
AU (1) AU2001254563A1 (en)
WO (1) WO2001083736A2 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2363483A3 (en) 2004-03-05 2014-07-16 Benitec, Inc. Multiple promoter expression cassettes for simultaneous delivery of RNAi agents
FR2901807B1 (en) * 2006-05-30 2013-08-23 Univ Victor Segalen Bordeaux 2 NEW TREATMENT OF HCV INFECTION
US9775894B2 (en) 2013-07-09 2017-10-03 University Of Washington Through Its Center For Commercialization Methods and compositions for activation of innate immune responses through RIG-I like receptor signaling

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6127116A (en) * 1995-08-29 2000-10-03 Washington University Functional DNA clone for hepatitis C virus (HCV) and uses thereof
AU2181800A (en) * 1998-12-10 2000-06-26 Eli Lilly And Company Primer-independent rna synthesis catalyzed by hcv polymerase

Also Published As

Publication number Publication date
WO2001083736A2 (en) 2001-11-08
US20010055756A1 (en) 2001-12-27
EP1278837A2 (en) 2003-01-29
WO2001083736A3 (en) 2002-08-01

Similar Documents

Publication Publication Date Title
AU2001253206A1 (en) Ns5b hcv polymerase inhibitors
AU2001249251A1 (en) Novel nucleic acids and polypeptides
AU2001243142A1 (en) Novel nucleic acids and polypeptides
AU2001234944A1 (en) Novel nucleic acids and polypeptides
AU2001245280A1 (en) Novel nucleic acids and polypeptides
AU2001233041A1 (en) Novel nucleic acids and polypeptides
AU2001238347A1 (en) Novel nucleic acids and polypeptides
AU6371900A (en) Lactam inhibitors of hepatitis c virus ns3 protease
AU2002246502A1 (en) Nucleic acids and polypeptides
AU2002259130A1 (en) Agents for treatment of hcv and methods of use
AU2001233017A1 (en) Novel nucleic acids and polypeptides
AU2001241511A1 (en) Novel nucleic acids and polypeptides
HUP0400039A3 (en) Hcv polymerase inhibitor assay
AU2001292732A1 (en) Beta-lactam analogs and uses therefor
AU2001292561A1 (en) Nucleic acids and polypeptides
AU2002211370A1 (en) Inhibition of tgf-beta and uses thereof
AU2001250872A1 (en) Novel nucleic acids and polypeptides
AU2001258413A1 (en) Improved tablecloth and device for fixing the skirt of said tablecloth
AU2002303712A1 (en) Novel telomerase inhibitors and uses therefor
AU2001254563A1 (en) Internal de novo initiation sites of the hcv ns5b polymerase and use thereof
AU2002316577A1 (en) Cell-screening assay and composition
AUPR857401A0 (en) Printing cylinders and methods of construction
AU2002319176A1 (en) Polynucleotides and polypeptides of the ifnalpha-5 gene
AU2001264863A1 (en) Preparation of fagopyritols and uses therefor
AU2001276258A1 (en) Ceramic component and the use thereof